Important Release – Suspension of Silimed’s CE Certificate for Silicone Implants in Europe

Oct 2 2015

The suspension affects Silimed products in the European, Australian and New Zealand markets only. According to the Therapeutic Goods Administration (TGA), Australia’s regulatory authority, TüV Süd gave the reason that potential particles identified as microscopic silica and cotton were identified during a routine inspection of one of Silimed’s manufacturing facilities.